Class Action Signal

Class Action Signal

Class ActionsNews
Class ActionsNewsAboutContact
Public case information

Phreesia Securities Class Action

Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.

Phreesia · Phreesia common stock · Ongoing Litigation

Last updated

About this case

The action alleges that Phreesia made materially false or misleading statements about its fiscal 2027 revenue projections and the durability of pharmaceutical marketing commitments in its Network Solutions segment. The company reduced its fiscal 2027 revenue guidance on March 30, 2026, after which its shares reportedly declined; the matter is in the lead-plaintiff stage.

Case overview

Defendant company
Phreesia
Product or service
Phreesia common stock
Case name
Phreesia securities class action
Court case number
1:26-cv-00556
Case status
Ongoing Litigation
Lawsuit type
Securities
Reported harm
Misrepresentation

Important dates

Lead Plaintiff Application
Lead Plaintiff Representation Intake

Participation information

Availability is based on each listed participation option and its deadline.

Lead Plaintiff Application

Investors who acquired eligible Phreesia securities during the alleged class period of May 8, 2025 through March 30, 2026 could seek appointment as lead plaintiff.

Lead-plaintiff applications were required by July 13, 2026. Investors who take no action may remain absent class members.

Type
Lead Plaintiff
Status
Deadline passed
Reported proof requirement
Unclear

Lead Plaintiff Representation Intake

Investors who purchased Phreesia shares during the alleged class period may have been able to seek appointment as lead plaintiff or discuss potential representation with the law firm.

Contact Levi & Korsinsky regarding the Phreesia recovery action.

Type
Law Firm Signup
Status
Deadline passed
Reported proof requirement
Unclear

Investor Legal Rights Consultation

The announcement invites people who purchased or acquired Phreesia common stock during the stated period to discuss their legal rights.

Contact Bragar Eagel & Squire at (212) 355-4648 to discuss participation in the action.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear

Bronstein, Gewirtz & Grossman investor inquiry

The law firm states that it represents investors in securities class actions and invites Phreesia investors to contact it.

Contact Bronstein, Gewirtz & Grossman using the contact information provided in the article.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear
BusinessWire source

This information does not determine whether you qualify for a case.

Sources

Public reporting associated with this case.